HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Combined diphtheria-tetanus-pertussis vaccine for tetanus-prone wound management in adults.

AbstractINTRODUCTION:
Booster vaccination against tetanus, diphtheria and pertussis is recommended throughout life. Adults are difficult to reach and vaccination coverage in this group is often inadequate. The use of a reduced-antigen content combined diphtheria-tetanus-acellular pertussis ('adult' dTpa) vaccine for tetanus prophylaxis in emergency room wound management provides an opportunity to boost immunity against three infections simultaneously, thereby optimizing the efficiency of medical interventions with adults assessed.
METHODS:
A single-blind, randomized, controlled study of 320 healthy adults, the anti-tetanus antibody response within 10 days following vaccination with Boostrix (reduced-antigen diphtheria-tetanus-acellular pertussis).
RESULTS:
The anti-tetanus antibody response to the reduced-antigen diptheria-tetanus-acellular pertussis vaccine was equivalent to Tetavax, a licensed monovalent tetanus-toxoid vaccine.
CONCLUSION:
The use of diphtheria-tetanus-acellular pertussis is a safe and effective way to provide vaccination to adults against three diseases during emergency room visits for wound management.
AuthorsTerje Hoel, Joanne M Wolter, Lode M Schuerman
JournalEuropean journal of emergency medicine : official journal of the European Society for Emergency Medicine (Eur J Emerg Med) Vol. 13 Issue 2 Pg. 67-71 (Apr 2006) ISSN: 0969-9546 [Print] England
PMID16525231 (Publication Type: Comparative Study, Journal Article, Multicenter Study, Randomized Controlled Trial)
Chemical References
  • Antibodies, Bacterial
  • Boostrix
  • Diphtheria-Tetanus-Pertussis Vaccine
Topics
  • Adult
  • Aged
  • Antibodies, Bacterial (blood)
  • Clostridium tetani (immunology)
  • Diphtheria-Tetanus-Pertussis Vaccine (adverse effects, immunology)
  • Emergency Medical Services
  • Female
  • Humans
  • Immunization, Secondary
  • Male
  • Middle Aged
  • Single-Blind Method
  • Tetanus (immunology, prevention & control)
  • Wound Infection (prevention & control)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: